Presynaptic specificity of endocannabinoid signaling in the hippocampus.

The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev (2006) 6.80

The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron (2006) 4.12

Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci (2010) 3.11

Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci U S A (2002) 2.95

Endocannabinoid signaling and long-term synaptic plasticity. Annu Rev Physiol (2009) 2.35

Endocannabinoid signaling and synaptic function. Neuron (2012) 1.90

Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha. Neuron (2007) 1.81

Perisomatic GABA release and thalamocortical integration onto neocortical excitatory cells are regulated by neuromodulators. Neuron (2008) 1.80

Supply and demand for endocannabinoids. Trends Neurosci (2011) 1.78

Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci U S A (2009) 1.75

Activity-dependent regulation of synapses by retrograde messengers. Neuron (2009) 1.73

Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci U S A (2004) 1.64

Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning. Hippocampus (2015) 1.63

Asynchronous transmitter release from cholecystokinin-containing inhibitory interneurons is widespread and target-cell independent. J Neurosci (2009) 1.60

Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning. Proc Natl Acad Sci U S A (2011) 1.60

Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling. Cell (2013) 1.58

Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons. Nature (2013) 1.54

Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci (2010) 1.48

Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol Pharmacol (2009) 1.46

Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.44

Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol (2004) 1.35

Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci (2010) 1.32

Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J Physiol (2011) 1.32

The maturation of GABAergic transmission in visual cortex requires endocannabinoid-mediated LTD of inhibitory inputs during a critical period. Neuron (2010) 1.32

Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc Natl Acad Sci U S A (2005) 1.30

Basket cell dichotomy in microcircuit function. J Physiol (2011) 1.30

Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin. Proc Natl Acad Sci U S A (2008) 1.27

Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J Physiol (2005) 1.26

Cyclooxygenase-2 in synaptic signaling. Curr Pharm Des (2008) 1.26

Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. Eur J Neurosci (2005) 1.26

Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J Neurosci (2010) 1.24

Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn Mem (2007) 1.24

Complementary modulation of somatic inhibition by opioids and cannabinoids. J Neurosci (2008) 1.23

Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice. Psychopharmacology (Berl) (2004) 1.23

Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J Neurosci (2010) 1.22

Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol (2006) 1.22

Differential dependence of phasic transmitter release on synaptotagmin 1 at GABAergic and glutamatergic hippocampal synapses. Proc Natl Acad Sci U S A (2008) 1.21

Altering cannabinoid signaling during development disrupts neuronal activity. Proc Natl Acad Sci U S A (2005) 1.21

New dimensions of interneuronal specialization unmasked by principal cell heterogeneity. Trends Neurosci (2011) 1.20

Molecular signals of plasticity at the tetrapartite synapse. Curr Opin Neurobiol (2011) 1.20

Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. J Neurosci (2010) 1.19

Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol (2004) 1.19

Signaling via CNS cannabinoid receptors. Mol Cell Endocrinol (2008) 1.18

Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther (2006) 1.15

Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nat Neurosci (2014) 1.14

GABA B receptor modulation of excitatory and inhibitory synaptic transmission onto rat CA3 hippocampal interneurons. J Physiol (2003) 1.14

Cannabinoid sensitivity and synaptic properties of 2 GABAergic networks in the neocortex. Cereb Cortex (2008) 1.12

Differential expression of posttetanic potentiation and retrograde signaling mediate target-dependent short-term synaptic plasticity. Neuron (2007) 1.11

Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca²⁺ channels and Ca²⁺ release from stores. J Neurosci (2011) 1.10

Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others. Neuropharmacology (2007) 1.10

Cannabinoid signaling in inhibitory autaptic hippocampal neurons. Neuroscience (2009) 1.10

Selective reduction of cholecystokinin-positive basket cell innervation in a model of temporal lobe epilepsy. J Neurosci (2010) 1.09

Distinct synaptic properties of perisomatic inhibitory cell types and their different modulation by cholinergic receptor activation in the CA3 region of the mouse hippocampus. Eur J Neurosci (2010) 1.09

Endocannabinoid tone versus constitutive activity of cannabinoid receptors. Br J Pharmacol (2011) 1.05

Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. Br J Pharmacol (2007) 1.04

The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J Neurosci (2008) 1.04

Presynaptic NMDA Receptors and Spike Timing-Dependent Depression at Cortical Synapses. Front Synaptic Neurosci (2010) 1.03

A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. Alcohol (2012) 1.02

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality. Life Sci (2009) 1.01

Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl) (2009) 1.01

Modulation of presynaptic Ca2+ entry by AMPA receptors at individual GABAergic synapses in the cerebellum. J Neurosci (2005) 1.01

Endocannabinoids differentially modulate synaptic plasticity in rat hippocampal CA1 pyramidal neurons. PLoS One (2010) 1.01

Cholinergic modulation of hippocampal network function. Front Synaptic Neurosci (2013) 1.01

Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons. J Physiol (2007) 1.00

Endocannabinoids and their implications for epilepsy. Epilepsy Curr (2005) 1.00

Signal transduction via cannabinoid receptors. CNS Neurol Disord Drug Targets (2009) 0.99

Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus. Proc Natl Acad Sci U S A (2008) 0.98

Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years. AAPS J (2006) 0.98

Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J Psychopharmacol (2011) 0.97

Assortment of GABAergic plasticity in the cortical interneuron melting pot. Neural Plast (2011) 0.95

The therapeutic potential of novel cannabinoid receptors. Pharmacol Ther (2009) 0.95

Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission. J Physiol (2015) 0.95

Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. Br J Pharmacol (2012) 0.94

Subchronic treatment with antiepileptic drugs modifies pentylenetetrazol-induced seizures in mice: Its correlation with benzodiazepine receptor binding. Neuropsychiatr Dis Treat (2008) 0.94

CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2. Neuropharmacology (2007) 0.94

Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells. J Physiol (2010) 0.94

Endocannabinoids generated by Ca2+ or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase. PLoS One (2011) 0.92

Cannabinoids and Epilepsy. Neurotherapeutics (2015) 0.91

Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline. Psychopharmacology (Berl) (2004) 0.91

Endocannabinoids block status epilepticus in cultured hippocampal neurons. Eur J Pharmacol (2006) 0.91

Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. Curr Neuropharmacol (2007) 0.90

Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.90

Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum. J Physiol (2004) 0.89

Presynaptic kainate receptor activation preserves asynchronous GABA release despite the reduction in synchronous release from hippocampal cholecystokinin interneurons. J Neurosci (2010) 0.89

Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction. Front Psychiatry (2013) 0.88

Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology (2011) 0.87

Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology (2011) 0.87

Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors. J Biol Chem (2009) 0.87

Presynaptic LTP and LTD of excitatory and inhibitory synapses. Cold Spring Harb Perspect Biol (2012) 0.87

Heterogeneity and specificity of presynaptic Ca2+ current modulation by mGluRs at individual hippocampal synapses. Cereb Cortex (2004) 0.87

Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology. Neurotherapeutics (2012) 0.87

Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid signaling and affects hyperexcitability in a mouse model of fragile X syndrome. J Neurosci (2015) 0.86

Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system. Cold Spring Harb Perspect Med (2013) 0.86

CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling. Nat Neurosci (2013) 0.86

Functional coupling of diverse voltage-gated Ca(2+) channels underlies high fidelity of fast dendritic Ca(2+) signals during burst firing. J Physiol (2016) 0.86

Presynaptic mechanisms of neuronal plasticity and their role in epilepsy. Front Cell Neurosci (2014) 0.86

Cannabinoid receptors contribute to astroglial Ca²⁺-signalling and control of synaptic plasticity in the neocortex. Philos Trans R Soc Lond B Biol Sci (2014) 0.86

Developmental alteration of endocannabinoid retrograde signaling in the hippocampus. J Neurophysiol (2009) 0.86

Miniature IPSCs in hippocampal granule cells are triggered by voltage-gated Ca2+ channels via microdomain coupling. J Neurosci (2012) 0.85

Sticking out of the crowd: the molecular identity and development of cholecystokinin-containing basket cells. J Physiol (2012) 0.85

Long-term potentiation--a decade of progress? Science (1999) 10.24

Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature (2001) 6.36

PSD-95 involvement in maturation of excitatory synapses. Science (2000) 6.15

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature (2001) 6.12

Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature (2001) 5.98

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A (1999) 5.75

Evidence for silent synapses: implications for the expression of LTP. Neuron (1995) 5.60

Learning mechanisms: the case for CaM-KII. Science (1997) 4.62

Role of AMPA receptor cycling in synaptic transmission and plasticity. Neuron (1999) 4.41

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31

Control of the repetitive discharge of rat CA 1 pyramidal neurones in vitro. J Physiol (1984) 3.71

Two distinct Ca-dependent K currents in bullfrog sympathetic ganglion cells. Proc Natl Acad Sci U S A (1985) 3.66

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A (1999) 3.54

G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron (1997) 3.52

A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science (1986) 3.17

Comparison of two forms of long-term potentiation in single hippocampal neurons. Science (1990) 3.15

Properties of two calcium-activated hyperpolarizations in rat hippocampal neurones. J Physiol (1987) 3.12

Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. J Neurophysiol (1993) 3.07

Analysis of excitatory synaptic action in pyramidal cells using whole-cell recording from rat hippocampal slices. J Physiol (1990) 3.04

Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells. Neuron (1997) 3.01

Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science (1988) 3.00

Local and diffuse synaptic actions of GABA in the hippocampus. Neuron (1993) 2.92

Dynamin-dependent endocytosis of ionotropic glutamate receptors. Proc Natl Acad Sci U S A (1999) 2.91

Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science (1994) 2.84

An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature (1989) 2.83

Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science (1989) 2.79

NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci (1993) 2.76

A physiological role for GABAB receptors in the central nervous system. Nature (1988) 2.71

Epileptiform burst afterhyperolarization: calcium-dependent potassium potential in hippocampal CA1 pyramidal cells. Science (1980) 2.69

Prolongation of hippocampal inhibitory postsynaptic potentials by barbiturates. Nature (1975) 2.67

Comparison of the action of baclofen with gamma-aminobutyric acid on rat hippocampal pyramidal cells in vitro. J Physiol (1985) 2.67

Postsynaptic membrane fusion and long-term potentiation. Science (1998) 2.59

Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature (1997) 2.52

Noradrenaline blocks accommodation of pyramidal cell discharge in the hippocampus. Nature (1982) 2.51

Synaptic plasticity and dynamic modulation of the postsynaptic membrane. Nat Neurosci (2000) 2.41

A persistent postsynaptic modification mediates long-term potentiation in the hippocampus. Neuron (1988) 2.40

Pharmacological evidence for two kinds of GABA receptor on rat hippocampal pyramidal cells studied in vitro. J Physiol (1982) 2.39

Development of excitatory circuitry in the hippocampus. J Neurophysiol (1998) 2.36

Silent synapses during development of thalamocortical inputs. Neuron (1997) 2.33

Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures. Nat Neurosci (1999) 2.32

Distinct short-term plasticity at two excitatory synapses in the hippocampus. Proc Natl Acad Sci U S A (1996) 2.32

Activity differentially regulates the surface expression of synaptic AMPA and NMDA glutamate receptors. Proc Natl Acad Sci U S A (1998) 2.28

The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci (2000) 2.28

Rab3A is essential for mossy fibre long-term potentiation in the hippocampus. Nature (1997) 2.27

Feed-forward dendritic inhibition in rat hippocampal pyramidal cells studied in vitro. J Physiol (1982) 2.27

Ca2+ signaling requirements for long-term depression in the hippocampus. Neuron (1996) 2.21

Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol (1987) 2.18

Voltage clamp analysis of cholinergic action in the hippocampus. J Neurosci (1987) 2.17

Potentiation of synaptic transmission in the hippocampus by phorbol esters. Nature (1986) 2.16

Cyclic AMP mediates a presynaptic form of LTP at cerebellar parallel fiber synapses. Neuron (1996) 2.15

All-or-none potentiation at CA3-CA1 synapses. Proc Natl Acad Sci U S A (1998) 2.06

Mechanisms generating the time course of dual component excitatory synaptic currents recorded in hippocampal slices. Neuron (1990) 2.05

Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension (1999) 2.03

Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature (1997) 2.03

Calcium/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism. Proc Natl Acad Sci U S A (1995) 2.03

Synaptic activation of kainate receptors on hippocampal interneurons. Nat Neurosci (1998) 2.03

Characterization of a slow cholinergic post-synaptic potential recorded in vitro from rat hippocampal pyramidal cells. J Physiol (1984) 2.01

The pharmacology and ionic dependency of amino acid responses in the frog spinal cord. J Physiol (1973) 1.99

Effects of reduced vesicular filling on synaptic transmission in rat hippocampal neurones. J Physiol (2000) 1.98

Direct hyperpolarizing action of baclofen on hippocampal pyramidal cells. Nature (1984) 1.98

GABA-mediated biphasic inhibitory responses in hippocampus. Nature (1979) 1.97

Evidence favouring the existence of a single adrenergic receptor. Nature (1968) 1.96

Postsynaptically silent synapses in single neuron cultures. Neuron (1998) 1.94

A bicuculline-resistant inhibitory post-synaptic potential in rat hippocampal pyramidal cells in vitro. J Physiol (1984) 1.92

A simple chamber for recording from submerged brain slices. J Neurosci Methods (1981) 1.89

Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J (1998) 1.89

Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther (1997) 1.87

Contribution of cytoskeleton to the internalization of AMPA receptors. Proc Natl Acad Sci U S A (2001) 1.83

Climate change and the integrity of science. Science (2010) 1.80

Pre- and postsynaptic GABAB receptors in the hippocampus have different pharmacological properties. Neuron (1988) 1.80

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med (2001) 1.80

Long-term potentiation is associated with increases in quantal content and quantal amplitude. Nature (1992) 1.76

Studies on convulsants in the isolated frog spinal cord. I. Antagonism of amino acid responses. J Physiol (1975) 1.76

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature (1997) 1.76

Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J (2000) 1.75

Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol (1996) 1.75

Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension (1997) 1.75

Cyclic adenosine 3',5'-monophosphate mediates beta-receptor actions of noradrenaline in rat hippocampal pyramidal cells. J Physiol (1986) 1.75

The role of Ca2+ channels in hippocampal mossy fiber synaptic transmission and long-term potentiation. Neuron (1994) 1.74

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol (1995) 1.72

Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses. Science (2001) 1.71

Postsynaptic contribution to long-term potentiation revealed by the analysis of miniature synaptic currents. Nature (1992) 1.71

Acetylcholine mediates a slow synaptic potential in hippocampal pyramidal cells. Science (1983) 1.70

Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc Natl Acad Sci U S A (1996) 1.69

Pentobarbital: action on frog motoneurons. Brain Res (1975) 1.69

Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurones, in vitro. J Physiol (1986) 1.69

The effects of anaesthetics on synaptic excitation and inhibition in the olfactory bulb. J Physiol (1972) 1.69

Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development. Proc Natl Acad Sci U S A (2008) 1.68

Mechanisms underlying long-term potentiation of synaptic transmission. Annu Rev Neurosci (1991) 1.68

Bidirectional control of quantal size by synaptic activity in the hippocampus. Science (1996) 1.67

Excitatory synaptic currents in Purkinje cells. Proc Biol Sci (1990) 1.64

Substance P as a transmitter candidate. Annu Rev Neurosci (1980) 1.64

Calcium activates two types of potassium channels in rat hippocampal neurons in culture. J Neurosci (1991) 1.63

Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry (2012) 1.63

Classification of muscarinic responses in hippocampus in terms of receptor subtypes and second-messenger systems: electrophysiological studies in vitro. J Neurosci (1988) 1.63

Presynaptic changes during mossy fibre LTP revealed by NMDA receptor-mediated synaptic responses. Nature (1995) 1.61

Enkephalin hyperpolarizes interneurones in the rat hippocampus. J Physiol (1988) 1.61

Release of adenosine by activation of NMDA receptors in the hippocampus. Science (1994) 1.60

Long-term potentiation in cultures of single hippocampal granule cells: a presynaptic form of plasticity. Neuron (1996) 1.57

Synaptic plasticity at thalamocortical synapses in developing rat somatosensory cortex: LTP, LTD, and silent synapses. J Neurobiol (1999) 1.55